78 related articles for article (PubMed ID: 19239137)
1. Beneficial effect of taurine treatment against doxorubicin-induced cardiotoxicity in mice.
Ito T; Muraoka S; Takahashi K; Fujio Y; Schaffer SW; Azuma J
Adv Exp Med Biol; 2009; 643():65-74. PubMed ID: 19239137
[TBL] [Abstract][Full Text] [Related]
2. Reduction of doxorubicin-induced cardiotoxicity in mice by taurine.
Hamaguchi T; Azuma J; Awata N; Ohta H; Takihara K; Harada H; Kishimoto S; Sperelakis N
Res Commun Chem Pathol Pharmacol; 1988 Jan; 59(1):21-30. PubMed ID: 3353577
[TBL] [Abstract][Full Text] [Related]
3. Overweight in mice, induced by perinatal programming, exacerbates doxorubicin and trastuzumab cardiotoxicity.
Guenancia C; Hachet O; Aboutabl M; Li N; Rigal E; Cottin Y; Rochette L; Vergely C
Cancer Chemother Pharmacol; 2016 Apr; 77(4):777-85. PubMed ID: 26914236
[TBL] [Abstract][Full Text] [Related]
4. Alleviation of the acute doxorubicin-induced cardiotoxicity by Lycium barbarum polysaccharides through the suppression of oxidative stress.
Xin YF; Wan LL; Peng JL; Guo C
Food Chem Toxicol; 2011 Jan; 49(1):259-64. PubMed ID: 21056614
[TBL] [Abstract][Full Text] [Related]
5. Paradoxically, iron overload does not potentiate doxorubicin-induced cardiotoxicity in vitro in cardiomyocytes and in vivo in mice.
Guenancia C; Li N; Hachet O; Rigal E; Cottin Y; Dutartre P; Rochette L; Vergely C
Toxicol Appl Pharmacol; 2015 Apr; 284(2):152-62. PubMed ID: 25711856
[TBL] [Abstract][Full Text] [Related]
6. Taurine suppresses doxorubicin-triggered oxidative stress and cardiac apoptosis in rat via up-regulation of PI3-K/Akt and inhibition of p53, p38-JNK.
Das J; Ghosh J; Manna P; Sil PC
Biochem Pharmacol; 2011 Apr; 81(7):891-909. PubMed ID: 21295553
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in mice through SIRT1-mediated deacetylation of p53.
Zhang C; Feng Y; Qu S; Wei X; Zhu H; Luo Q; Liu M; Chen G; Xiao X
Cardiovasc Res; 2011 Jun; 90(3):538-45. PubMed ID: 21278141
[TBL] [Abstract][Full Text] [Related]
8. Epigallocatechin-3-gallate pretreatment attenuates doxorubicin-induced cardiotoxicity in rats: A mechanistic study.
Saeed NM; El-Naga RN; El-Bakly WM; Abdel-Rahman HM; Salah ElDin RA; El-Demerdash E
Biochem Pharmacol; 2015 Jun; 95(3):145-55. PubMed ID: 25701654
[TBL] [Abstract][Full Text] [Related]
9. Taurine Has Potential Protective Effects against the Chronic Cardiotoxicity Induced by Doxorubicin in Mice.
Zhang H; Guo J; Cui S; Zhou Y
Biol Pharm Bull; 2021; 44(11):1732-1737. PubMed ID: 34719649
[TBL] [Abstract][Full Text] [Related]
10. Exercise preconditioning protects against doxorubicin-induced cardiac dysfunction.
Hydock DS; Lien CY; Schneider CM; Hayward R
Med Sci Sports Exerc; 2008 May; 40(5):808-17. PubMed ID: 18408619
[TBL] [Abstract][Full Text] [Related]
11. Protection against doxorubicin cardiomyopathy in rats: role of phosphodiesterase inhibitors type 4.
Mohamed HE; Asker ME; Ali SI; el-Fattah TM
J Pharm Pharmacol; 2004 Jun; 56(6):757-68. PubMed ID: 15231041
[TBL] [Abstract][Full Text] [Related]
12. Persistent effects of doxorubicin on cardiac gene expression.
Boucek RJ; Miracle A; Anderson M; Engelman R; Atkinson J; Dodd DA
J Mol Cell Cardiol; 1999 Aug; 31(8):1435-46. PubMed ID: 10423342
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of arabic gum against cardiotoxicity induced by doxorubicin in mice: a possible mechanism of protection.
Abd-Allah AR; Al-Majed AA; Mostafa AM; Al-Shabanah OA; Din AG; Nagi MN
J Biochem Mol Toxicol; 2002; 16(5):254-9. PubMed ID: 12439867
[TBL] [Abstract][Full Text] [Related]
14. Antarth, a polyherbal preparation protects against the doxorubicin-induced toxicity without compromising its Antineoplastic activity.
Jagetia GC; Reddy TK; Malagi KJ; Nayak BS; Naidu MB; Ravikiran PB; Kamath SU; Shetty PC; Reddy DS
Phytother Res; 2005 Sep; 19(9):772-8. PubMed ID: 16220569
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mouse heart.
Sun X; Zhou Z; Kang YJ
Cancer Res; 2001 Apr; 61(8):3382-7. PubMed ID: 11309296
[TBL] [Abstract][Full Text] [Related]
16. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration.
Saad SY; Najjar TA; Alashari M
J Biochem Mol Toxicol; 2004; 18(2):78-86. PubMed ID: 15122649
[TBL] [Abstract][Full Text] [Related]
17. Enhanced toxicity and ROS generation by doxorubicin in primary cultures of cardiomyocytes from neonatal metallothionein-I/II null mice.
Fu Z; Guo J; Jing L; Li R; Zhang T; Peng S
Toxicol In Vitro; 2010 Sep; 24(6):1584-91. PubMed ID: 20600803
[TBL] [Abstract][Full Text] [Related]
18. Dose-response relationship of dexrazoxane for prevention of doxorubicin-induced cardiotoxicity in mice, rats, and dogs.
Imondi AR; Della Torre P; Mazué G; Sullivan TM; Robbins TL; Hagerman LM; Podestà A; Pinciroli G
Cancer Res; 1996 Sep; 56(18):4200-4. PubMed ID: 8797592
[TBL] [Abstract][Full Text] [Related]
19. General oxidative stress during doxorubicin-induced cardiotoxicity in rats: absence of cardioprotection and low antioxidant efficiency of alpha-lipoic acid.
Ghibu S; Delemasure S; Richard C; Guilland JC; Martin L; Gambert S; Rochette L; Vergely C
Biochimie; 2012 Apr; 94(4):932-9. PubMed ID: 21396425
[TBL] [Abstract][Full Text] [Related]
20. Reversal of doxorubicin-induced cardiac metabolic damage by L-carnitine.
Sayed-Ahmed MM; Shaarawy S; Shouman SA; Osman AM
Pharmacol Res; 1999 Apr; 39(4):289-95. PubMed ID: 10208759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
